chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I notice breathing been difficult especially after the second dose; throat irritation and inflammation; throat irritation and inflammation; Feeling tired; Joint pain right shoulder towards my back all the way down to my feet; always cramps; lost of feelings; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Apr2021 10:15 (Lot number: 9900325) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Previous dose details:, Prev dose product: COVID 19, Prev dose Brand: Pfizer , Prev dose Brand unknown: False , Prev dose Lot number: 9492577, Prev dose Lot unknown: False, Prev dose Administration date: 09Apr2021, Prev dose Administration time: 10:15 AM, Prev dose Dose number: 1, Prev dose Vaccine location: Right arm), administration date: 09Apr2021, when the patient was 40 years old, for COVID-19 immunization. The following information was reported: DYSPNOEA (non-serious) with onset 07May2021 02:00, outcome "not recovered", described as "I notice breathing been difficult especially after the second dose"; THROAT IRRITATION (non-serious), INFLAMMATION (non-serious) all with onset 07May2021 02:00, outcome "not recovered" and all described as "throat irritation and inflammation"; FATIGUE (non-serious) with onset 07May2021 02:00, outcome "not recovered", described as "Feeling tired"; ARTHRALGIA (non-serious) with onset 07May2021 02:00, outcome "not recovered", described as "Joint pain right shoulder towards my back all the way down to my feet"; MUSCLE SPASMS (non-serious) with onset 07May2021 02:00, outcome "not recovered", described as "always cramps"; EMOTIONAL POVERTY (non-serious) with onset 07May2021 02:00, outcome "not recovered", described as "lost of feelings". Therapeutic measures were not taken as a result of dyspnoea, throat irritation, inflammation, fatigue, arthralgia, muscle spasms, emotional poverty.  Additional information: No other vaccine in four weeks. No Other medications in two weeks. Adverse event: Joint pain right shoulder towards his back all the way down to my feet and always cramps with lost of feelings now and then when the pain sercomed he notice breathing been difficult especially after the second dose with throat irritation and inflammation. Feeling tired when he haven't been doing anything all day was what he have notice after the vaccines. He had no Covid prior vaccination. He had no Covid tested post vaccination. He had None Known allergies and Other none medical history    Follow-up attempts are completed. No further information is expected.
Total body pain, sore injection site, dull headache, chills and severe shivering
shingles; ill defined disorder; This spontaneous report as received from a lawyer refers to a patient of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported.  On or about 03-OCT-2012, the patient was vaccinated with a dose of zoster vaccine live(ZOSTAVAX) for prophylaxis (dose, route, anatomical location, lot number and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions.         Subsequent, on unknown date, after zoster vaccine live(ZOSTAVAX) inoculation, the pt was treated by healthcare providers, including the physiciaN for shingles, and other zoster-related conditions. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), the pt had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
This spontaneous report was received from a pharmacist regarding an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates in between 22-MAR-2017 and 01-AUG-2017, the patients' received unspecified doses of improperly stored ZOSTAVAX 19400 PFU (lot #, expiration date, dose and route were not reported) (incorrect product storage) reconstituted with properly stored sterile diluent (Manufacturer unknown) for prophylaxis. The vaccinations were occurred from 22-MAR-2017 to 01-AUG-2017. The storage temperature was 13.3F and time frame was 2.5 hours. The previous temperature excursion was 14.4F for 2 hours. Data logger was not used. No adverse effects was reported. This is one of the report received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1708USA002351:
arthritis-like sx of hands, rt elbow & feet (possibly);swollen tender glands & trachea;
Pt recv vax on 12/16/98; on 12/17/98 pt exp myalgias, arthralgia, malaise, pruritic body rash, fever (100.2), local swelling of LA; tx=Benadryl, Proventil inhaler, Flovent inhaler
Papules, vesicles, scabbed vesicles on scalp & trunk about 40 lesions.  Diagnosis-Varicella  Treatment- Acyclovir
This case was reported by a physician via sales rep and described the occurrence of shoulder pain in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 8 hrs after receiving SHINGRIX, the patient experienced shoulder pain. On an unknown date, the outcome of the shoulder pain was unknown. It was unknown if the reporter considered the shoulder pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. After 8-10 hours later, the patient develop aseptic shoulder joint, shoulder pain. Cultures of joint fluid was found to be negative but white blood cell was found to be negative. The patient was hospitalized for 2 days. The reporter agree to follow up from GlaxoSmithKline. Lab Comments: Lab test was done on an unknown date.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date, the patient was administered with a dose of ZOSTAVAX post supported temperature excursion (0.65ml, subcutaneously, lot # L000450, expiration date: 09-MAR-2016). No adverse effects were reported. Follow up information has been received on 14-MAY-2015 and on 15-MAY-2015, from a pharmacist who was able to provide the patient's initials and dates of vaccination for the ZOSTAVAX that experienced a temperature excursion; it was stated that the patient of unknown age and gender was vaccinated on 07-APR-2015. The pharmacist had no additional information to provide at the time of the call. This is one of several reports from the same reporter. Additional information has been requested.
Caller reported an Improperly stored administered PROQUAD; This spontaneous report was received from a licensed Practical Nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not reported.   On 16-SEP-2020, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) (PROQUAD) (dosage regimen not provided) lot number T013539, expiration date 17-OCT-2021, recombinant human albumin (rHA) given as prophylaxis.   The improperly stored dose experienced a temperature excursion between 6 degree Fahrenheit (°F) and 14°F (average temperature of 11.7°F) for 25 minutes, as recorded by a data logger. There was no previous temperature excursion reported. No additional information was provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA008944: US-009507513-2009USA008968: US-009507513-2009USA008968: US-009507513-2009USA008941: US-009507513-2009USA009048: US-009507513-2009USA009094:
Worsening Tinnitus.  Never had Tinnitus until first set of Covid 10 Pfiser vaccine but gut worse after booster
patient said very sore and could not lift arm It was not red or swollen, within 1 hour pt shot on 11-13. Patient went to ER 11-15 with same symptom of soreness & could not lift arm. Doctor in ER said nothing to do but let pharmacy know. Patient called pharmacy 11-18. talked again 11-20 & is better now.
Pfizer BioNTech Covid 19 vaccine that was placed in the freezer on 27Oct2021 and were administered on 31Dec2021; Pfizer BioNTech Covid 19 vaccine that was placed in the freezer on 27Oct2021 and were administered on 31Dec2021; Pfizer BioNTech Covid 19 vaccine that was placed in the freezer on 27Oct2021 and were administered on 31Dec2021; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program. Other Case identifier(s): US-PFIZER INC-202200175752 (PFIZER).  A 16 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 31Dec2021 10:15 (Lot number: FF2590, Expiration Date: 31Mar2022) at the age of 16 years as dose 1, 0.3ml single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PRODUCT STORAGE ERROR (non-serious), EXPIRED PRODUCT ADMINISTERED (non-serious), POOR QUALITY PRODUCT ADMINISTERED (non-serious), outcome "unknown" and all described as "Pfizer BioNTech Covid 19 vaccine that was placed in the freezer on 27Oct2021 and were administered on 31Dec2021".  Additional information: LPN calling about two patients who received the Pfizer BioNTech Covid 19 vaccine that was placed in the freezer on 27Oct2021 and were administered on 31Dec2021.  Vaccine was never moved to the refrigerator.  The vaccines were first doses for 2 female patients ages 14 and 16.  Vaccine was not expired but used beyond use date because it was in the fridge beyond 14 days. This is for 1st of 2 reports. This was the patient's first dose of the covid vaccine that was administered 31Dec2021 around 10:15am. Reporter mentioned that they received email from Pfizer which says that there is no stability data to support the excursion. She mentioned the interaction number from the previous interaction. She also mentioned that it was sent back after they submitted the facility form to report their temperature excursion. She verbally read the email and mentioned that their vials were stored in a freezer from 27Oct2021 to 31Dec2021 and were administered. She wants to know if there is any revaccination guidelines for patients who received doses from the vials who experienced an excursion, given that there is no data to support their excursion.  No follow-up attempts are possible. No further information is expected.
Pt developed chickenpox type rash on body and legs 1-2 wks after vaccine.
sciatic nerve issues in my left hip running down my hamstrings / nerve issue; nerve pain; chills; headache; joint pains; extremely fatigued; weak of feeling like an old lady; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (sciatic nerve issues in my left hip running down my hamstrings / nerve issue), NEURALGIA (nerve pain), CHILLS (chills), HEADACHE (headache) and ARTHRALGIA (joint pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SCIATICA (sciatic nerve issues in my left hip running down my hamstrings / nerve issue), NEURALGIA (nerve pain), CHILLS (chills), HEADACHE (headache), ARTHRALGIA (joint pains), FATIGUE (extremely fatigued) and ASTHENIA (weak of feeling like an old lady). At the time of the report, SCIATICA (sciatic nerve issues in my left hip running down my hamstrings / nerve issue), NEURALGIA (nerve pain), CHILLS (chills), HEADACHE (headache), ARTHRALGIA (joint pains), FATIGUE (extremely fatigued) and ASTHENIA (weak of feeling like an old lady) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications and treatment medications was provided.
I took vaccine on 9th December but got hives on my back , under my breast, near vagina  thighs and rash on my arms and my vaccination site was swollen
pt recvd 1 dose of Engerix-B & immed following dose exp burning & aching muscle discomfort, & difficulty raising arm for 3 wks;
SPONTANEOUS ABORTION; VACCINE EXPOSURE BEFORE PREGNANCY; This spontaneous pregnancy report received from a consumer via media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was para 0, gravida 2.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient had vaccine exposure before pregnancy. The pregnancy resulted in a spontaneous abortion. Reporter stated, " I tried to warned as many people that would listen to me, not to take those dangerous shots Very few people would listen to me, and some are dead now for not doing so. One lady (Not in my Sunday School Class, but is a church member), had two miscarriages after taking them. Everyone (53 members) in my Sunday School class took the shots, even though I warned them good not to take the shots Almost everyone in my class has had COVID since taking the shots They are now mighty quite about it all, when they announce that a member of our class now has COVID Some have had COVID the second time around, and they are filled up with those dangerous chemicals and man made viruses, that they allowed stupid doctors to give to them. When I was warning them, some of them said stupid things to me for not being protected, and risking other people's lives by catching it, and spreading it I don't hear a peep out of any of them now I did my research and I listened to "Real Doctors" Less ".  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the spontaneous abortion and vaccine exposure before pregnancy was not reported. This report was serious (Other Medically Important Condition). This case, involving the same patient is linked to 20221258686. This case, from the same reporter is linked to 20221257674 and 20221257582.; Sender's Comments: V0: 20221260842- Spontaneous abortion. The event has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.  20221260842-Vaccine exposure before pregnancy . The event has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
3:00am 4/2/21 (14 hours after shot): fever 99.9 and muscle and joint pain which continued for approximately 24 hours after onset  8:00pm 4/5/21 (4 days after shot) extreme swelling, rash, and pain at/below injection site. Skin hot to the touch. Ongoing.
She developed red indurated area 7 cm in diameter on left deltoid where shot given, minimally tender. But itchy. Seen again 3/13-1.5cm area of induration faint, remains. No redness or tenderness.
approximately 6 hours after the booster (around 3pm) he felt ill.  at 7:30 pm his temperature was 99.6, he took two 500 mg of tylenol and went to bed.  at 3:30 am he was still feeling ill and still felt warm didn't check his temp with a thermometer however.  He took two more 500 mg of tylenol and went back to bed.   went back to bed after taking the tylenol and slept until 1pm the next day (today 1-21-2022).  He was thirsty but said he felt some better.  didn't take any tylenol but did drink some water.  he asked me for more tylenol at 2:20 pm i checked his temperature with a forehead scanning thermometer, his temp was 102.4
Recently discovered he has immunity to the vaccine; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient recently discovered that he has immunity to the vaccine on an unspecified date and wants to know if there have been other reports about this and what he should do. The outcome of event was unknown.  No further information provided or obtained.  Information about batch/lot number has been requested.
Bilateral nucal xantham well defined circular in nature. Intact, total of 7.
when rn administered vaccine, most came out of the hub and so a second dose was given to the patient.
a moderna vaccine given on the 8th to a patient and the vaccine expired on the 5th; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a moderna vaccine given on the 8th to a patient and the vaccine expired on the 5th) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (a moderna vaccine given on the 8th to a patient and the vaccine expired on the 5th) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a moderna vaccine given on the 8th to a patient and the vaccine expired on the 5th) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (a moderna vaccine given on the 8th to a patient and the vaccine expired on the 5th).    No concomitant information was reported. Suspect product dosage text was reported as unknown. It was reported that one of the patient was immunocompromised. No treatment information was provided.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), on 25Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 63 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing), notes: ADHD; "Cantelope" (unspecified if ongoing), notes: known allergies: Cantelope; "Tremor" (unspecified if ongoing), notes: Tremor. Concomitant medication(s) included: RAPAMYCIN; VALACYCLOVIR [VALACICLOVIR]; INNOPRAN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I was extremely cold and have had continuous "ringing' in my head.  It stays with me all the time.  However, it does not wake me up at night. But, it is there every waking moment.  It is loud.  It affects my hearing.  My vision is fuzzy at times. I'm exhausted.
She was hypotensive, tachycardic, elevated WBC, elevated lactic acid, nausea, headache, fever (101), muscle aches, chills
This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from Regulatory Authority. The reporter is the patient. A 73-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Feb2021 (Lot number: EN6201, Expiration Date: Jun2021) at the age of 73 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Medrol dose Pak, start date: 21Jan2021, stop date: 25Jan2021, for vertigo. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "unknown", described as "swollen lymph nodes in my neck". Additional information: Patient stated that her 2nd dose is due tomorrow. She has swollen lymph nodes in her neck. How long does it take before it disappears? She heard people suggest they can take TYLENOL and drink lots of water after the 2nd shot and others say don't take anything some before or after, any information. Patient is thrilled to have the Pfizer shot. she just wanted to make sure this was not going to get worse with the 2nd shot. Fingers crossed she can do it tomorrow. It's wonderful you are there to answer these questions." No follow-up attempts are possible. No further information is expected.
heart attack caused by this vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of heart attack in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced heart attack (serious criteria death and GSK medically significant). On an unknown date, the outcome of the heart attack was fatal. The reported cause of death was heart attack.   The reporter considered the heart attack to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's friend. The age at vaccination was not reported. The reporter stated that, his or her friend died due to heart attack from  the vaccine.; Reported Cause(s) of Death: Heart attack